Sun Pharma and Hikma enter into exclusive licensing agreement for ILUMYA for Middle East &… EP News Bureau Jun 15, 2020 ILUMYA (tildrakizumab) is an US FDA approved innovative IL-23p19 monoclonal antibody used for the treatment of adults with…
